ACKR1
Atypical chemokine receptor 1
Also known as: ACKR1_HUMAN, CCBP1, CD234, DARC, Dfy, FY, GPD
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q16570
- Gene
- ACKR1
- Ensembl
- ENSG00000213088
- Chromosome
- 1
- Canonical length
- 336 aa
- Protein class
- Blood group antigen proteins, CD markers, G-protein coupled receptors, Predicted membrane proteins, Transporters
OverviewNCBI Gene
The protein encoded by this gene is a glycosylated membrane protein and a non-specific receptor for several chemokines. The encoded protein is the receptor for the human malarial parasites Plasmodium vivax and Plasmodium knowlesi. Polymorphisms in this gene are the basis of the Duffy blood group system. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
336 residues, UniProt reviewed canonical sequence.
>Q16570|ACKR1
1 MGNCLHRAEL SPSTENSSQL DFEDVWNSSY GVNDSFPDGD YGANLEAAAP CHSCNLLDDS
61 ALPFFILTSV LGILASSTVL FMLFRPLFRW QLCPGWPVLA QLAVGSALFS IVVPVLAPGL
121 GSTRSSALCS LGYCVWYGSA FAQALLLGCH ASLGHRLGAG QVPGLTLGLT VGIWGVAALL
181 TLPVTLASGA SGGLCTLIYS TELKALQATH TVACLAIFVL LPLGLFGAKG LKKALGMGPG
241 PWMNILWAWF IFWWPHGVVL GLDFLVRSKL LLLSTCLAQQ ALDLLLNLAE ALAILHCVAT
301 PLLLALFCHQ ATRTLLPSLP LPEGWSSHLD TLGSKSLocalizationUniProt · AlphaFold · HPA
Whether an antibody against ACKR1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 7
- Mean surface accessibility (rSASA)
- 0.37
- Highest tissue expression
- 388 nTPM
Expression across tissuesHPA
Tissue
- adipose tissue: 388 nTPM
- breast: 337 nTPM
- blood vessel: 176 nTPM
- lung: 175 nTPM
- fallopian tube: 160 nTPM
- vagina: 139 nTPM
Single-cell type
- vascular endothelial cells: 896 nCPM
- retinal bipolar cells: 55 nCPM
- lymphatic endothelial cells: 43 nCPM
- thymic myoid cells: 26 nCPM
- erythrocyte progenitors: 22 nCPM
- salivary myoepithelial cells: 17 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- cerebellum: 47 nTPM
- cerebral cortex: 32 nTPM
- spinal cord: 28 nTPM
- pons: 23 nTPM
- white matter: 21 nTPM
- choroid plexus: 20 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about ACKR1.
Disease | GeneticClinVar
2 pathogenic / likely-pathogenic of 55 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- DUFFY BLOOD GROUP SYSTEM, FY(a-b-) PHENOTYPE
- White blood cell count quantitative trait locus 1
- Resistance to Plasmodium vivax infection
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.6
- gnomAD pLI
- 0
- DepMap mean gene effect
- 0.02
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
- C-C chemokine binding
- G protein-coupled receptor activity
- signaling receptor activity
- transmembrane signaling receptor activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Duffy antigen/chemokine receptor
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads ACKR1 as an antibody target. Whether an autoantibody or antibody against ACKR1 could matter depends on whether native ACKR1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
ACKR1 is annotated at the cell surface, where native ACKR1 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label ACKR1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...